Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
At a glance GLP-1 medicines such as Ozempic, Wegovy, and Mounjaro do far more than help with weight loss
Researchers are asking why There is mounting evidence to suggest GLP-1 obesity treatments also help reduce cancer risk, according to several recent studies
Diabetes Obes Metab 23:529 Holst JJ (2019) The incretin system in healthy humans: The role of GIP and GLP-1
Quick Answer: A microdose of GLP-1 is an informal term for using GLP-1 receptor agonist medications at doses substantially lower than those licensed by UK regulatory authorities, an approach that is not evidence-based or recommended
When combined with a healthy diet and regular exercise, Semaglutide can be highly effective in helping individuals lose weight